CEA is a tumor marker that is useful to monitor patients with persistent, or for recurrent or metastatic colonic carcinoma. As many as 30% of patients with breast, lung, hepatocellular, and pancreatic carcinoma also have elevated concentrations of CEA. Individuals who smoke may have a slightly higher baseline than non-smokers.
Reported (Analytical Time)
The CPT codes provided are based on AMA guidelines and are for informational purposes only.
CPT coding is the sole responsibility of the billing party.
Please direct any questions regarding coding to the payer being billed.
Transport Temperature: Frozen Assay Category: FDA Approved/Modified Reject Criteria: Gross hemolysis